MyMD Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYMD and other ETFs, options, and stocks.

About MYMD

MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. It focuses on developing and commercializing the MyMD-1 and SUPERA-CBD therapeutic platforms. 

CEO
Christopher C. Chapman, Jr., MD
CEOChristopher C. Chapman, Jr., MD
Employees
Employees
Headquarters
Baltimore, Maryland
HeadquartersBaltimore, Maryland
Founded
1989
Founded1989
Employees
Employees

MYMD Key Statistics

Market cap
61.97M
Market cap61.97M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
166.57K
Average volume166.57K
High today
$1.62
High today$1.62
Low today
$1.45
Low today$1.45
Open price
$1.47
Open price$1.47
Volume
111.81K
Volume111.81K
52 Week high
$7.45
52 Week high$7.45
52 Week low
$1.44
52 Week low$1.44

MYMD Earnings

-$0.50
-$0.33
-$0.17
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 27
ActualExpected Mar 27
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.